Group 1 - Cathie Wood, founder and CEO of Ark Invest, is experiencing a positive year, with expectations to outperform the market in 2025, although not yet at her peak 2020 performance [1] - Ark Invest has been actively buying shares, including Alibaba, Intellia Therapeutics, and Baidu, indicating a strategic focus on high-stakes biotech and leading Chinese tech companies [2][7] Group 2 - Alibaba's stock has more than doubled this year, increasing by 112%, despite facing slowing growth with quarterly revenue gains in the single digits [3] - The company is the second largest by market cap on U.S. exchanges and is currently valued at 21 times trailing earnings, suggesting it remains reasonably priced [4] - Alibaba's domestic e-commerce business contributes significantly to its earnings, accounting for less than half of its revenue but 113% of its consolidated adjusted EBITDA, highlighting its strong cash flow despite losses in other segments [5] - The ongoing trade war may be benefiting Alibaba, as its e-commerce operations continue to thrive while it invests in streaming services, cloud hosting, and AI chips [6]
Cathie Wood Goes Shopping: 3 Rising Stocks She Just Bought